The drugs’ active ingredient, glatiramer acetate, has been linked to more than 80 cases of anaphylaxis worldwide since ...

The menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women.

Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...

Nov. 18, 2024 — Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in ...

The onset of multiple sclerosis (MS) in older individuals correlates with a higher risk of developing primary progressive MS, faster progression to secondary progressive MS, and increased disability ...

Researchers don’t yet fully understand what causes multiple sclerosis (MS) but believe it may develop from a combination of genetic and environmental factors. Identifying these factors can help ...

Multiple sclerosis (MS) is one of the most widespread disabling neurological conditions of young adults around the world. It affects almost 1 million people in the United States, and about 2.9 ...

During his departure announcement in 2024, Neil thanked his bosses for their patience when he took off “a day or two here and there battling everything from multiple sclerosis and COVID to ...

For many people with RA, its effects include rashes in different areas of the skin. In some cases, skin rashes are related to RA or RA treatments, but some skin issues aren’t connected to ...

The study recommends emergency departments treat poison ivy rashes for a minimum of 2 to 3 weeks to help reduce the need for a return visit. Learn more about treatment options for a poison ivy rash.